Pharma IQ | 06/03/2010
Andrew Owen, Senior Lecturer at the MRC Centre for Drug Safety Science at the University of Liverpool, talks to us about the latest developments within the field of Pharmacogenetics, the strengths and limitations of strategies for potential areas of exploration, and where the major knowledge gaps are today.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More